Price
Target price
€255.90
€255.90
-2.870%
-7.6
-2.870%
€298.10
24.10.25 / Tradegate
WKN: 864330 / Symbol: WST / Name: West Pharmaceutical Services / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
West Pharmaceutical Services Inc. Stock
A loss of -2.870% shows a downward development for West Pharmaceutical Services Inc..
West Pharmaceutical Services Inc. is currently one of the favorites of our community with 13 Buy predictions and no Sell predictions.
With a target price of 298 € there is a slightly positive potential of 16.45% for West Pharmaceutical Services Inc. compared to the current price of 255.9 €.
Pros and Cons of West Pharmaceutical Services Inc. in the next few years
Pros
?
B****
?
M***** P*******
?
S********** s********
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of West Pharmaceutical Services Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| West Pharmaceutical Services Inc. | -2.870% | 10.397% | 14.497% | -10.305% | -19.604% | 1.286% | 7.521% |
| Haemonetics Corp. | -0.460% | 1.887% | 7.463% | -37.391% | -42.781% | -46.335% | -51.186% |
| Neogen Corp. | 0.950% | 5.941% | 15.801% | -57.540% | -55.417% | - | - |
| Merit Medical Systems | -3.420% | 1.439% | 4.444% | -19.429% | -22.951% | 19.492% | 74.505% |
Comments
West Pharmaceutical Services (NYSE:WST) was given a new $345.00 price target on by analysts at Deutsche Bank Aktiengesellschaft. They now have a "buy" rating on the stock.
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (NYSE:WST) had its price target raised by analysts at KeyCorp from $325.00 to $350.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (NYSE:WST) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Show more
Ratings data for WST provided by MarketBeat
News
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceuticals
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) and reminds
